Usefulness of PFC-FD in cases of implantation failure associated with endometrial thinning

Usefulness of PFC-FD in cases of implantation failure associated with endometrial thinning - Study on the usefulness of PFC-FD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043812

Enrollment

100

Registered

2021-04-05

Start date

2021-04-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial thinning,recurret implantation failure

Interventions

Intra-uterine injection of PFC-FD

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: mplantation failure more than three times, less than 8.0 mm of endometrium at the time of implantation

Exclusion criteria

Exclusion criteria: autoimmune disorders, sexually transmitted diseases, infectious diseases, tubal factor infertility/tubal obstruction, chronic inflammatory diseases, endometriosis, chronic endometritis, and endocrine disorders such as thyroid dysfunction,were excluded in general. Body Mass Index (BMI) above 30 or less than 18.5, hypothalamic-pituitary disorders

Design outcomes

Primary

Measure	Time frame
pregnancy rate	—

Secondary

Measure	Time frame
Endometrial thickness, fertility rate, and abortion rate	—

Countries

Japan

Contacts

Public ContactDAISUKE KADOGAMI

IVF Namba Clinic Doctor

kadogami515@ivfjapan.com0665348824

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026